Evaluation of clinical utility of serum choline level as a marker of non-alcoholic steatohepatitis.

Evaluation of clinical utility of serum choline level as a marker of non-alcoholic steatohepatitis. - Evaluation of clinical utility of serum choline level as a marker of non-alcoholic steatohepatitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003686

Enrollment

200

Registered

2010-06-02

Start date

2010-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver diseases (Simple steatosis of the liver and non-alcoholic steatohepatitis).

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with non-alcoholic fatty liver diseases who underwent percutaneous liver biopsy.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Evaluation of the association between non-alcoholic steatohepatitis and serum choline level.	—

Countries

Japan

Contacts

Public ContactRie Nishiwaki

Gifu University Graduate School of Medicine Department of Pharmacology

riemn@gifu-u.ac.jp058-230-6217

Outcome results